» Articles » PMID: 34583640

Role of Long Non-coding RNA H19 in the Development of Osteoporosis

Overview
Journal Mol Med
Publisher Biomed Central
Date 2021 Sep 29
PMID 34583640
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteoporosis is a widespread and serious metabolic bone disease. At present, revealing the molecular mechanisms of osteoporosis and developing effective prevention and treatment methods are of great significance to health worldwide. LncRNA is a non-coding RNA peptide chain with more than 200 nucleotides. Researchers have identified many lncRNAs implicated in the development of diseases and lncRNA H19 is an example.

Results: A large amount of evidence supports the fact that long non-coding RNA (lncRNA) genes, such as H19, have multiple, far-reaching effects on various biological functions. It has been found that lncRNA H19 has a role in the regulation of different types of cells in the body including the osteoblasts, osteocytes, and osteoclasts found in bones. Therefore, it can be postulated that lncRNA H19 affects the incidence and development of osteoporosis.

Conclusion: The prospect of targeting lncRNA H19 in the treatment of osteoporosis is promising because of the effects that lncRNA H19 has on the process of osteogenic differentiation. In this review, we summarize the molecular pathways and mechanisms of lncRNA H19 in the pathogenesis of osteoporosis and summarize the research progress of targeting H19 as a treatment option. Research is emerging that explores more effective treatment possibilities for bone metabolism diseases using molecular targets.

Citing Articles

Targeting Long Noncoding RNA H19 in Subchondral Bone Osteocytes and the Alleviation of Cartilage Degradation in Osteoarthritis.

Wang R, Mehrjou B, Dehghan-Banian D, Wang B, Li Q, Deng S Arthritis Rheumatol. 2024; 77(3):283-297.

PMID: 39482250 PMC: 11865692. DOI: 10.1002/art.43028.


Genetics and pathogenesis of scoliosis.

Petrosyan E, Fares J, Ahuja C, Lesniak M, Koski T, Dahdaleh N N Am Spine Soc J. 2024; 20:100556.

PMID: 39399722 PMC: 11470263. DOI: 10.1016/j.xnsj.2024.100556.


Diabetic Cardiomyopathy: Role of Cell Death, Exosomes, Fibrosis and Epicardial Adipose Tissue.

Galeone A, Annicchiarico A, Buccoliero C, Barile B, Luciani G, Onorati F Int J Mol Sci. 2024; 25(17).

PMID: 39273428 PMC: 11395197. DOI: 10.3390/ijms25179481.


Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects.

Jiang C, Wang P, Tan Z, Zhang Y Open Life Sci. 2024; 19(1):20220908.

PMID: 39156986 PMC: 11330173. DOI: 10.1515/biol-2022-0908.


Aucubin Promotes Osteogenic Differentiation and Facilitates Bone Formation through the lncRNA-H19 Driven Wnt/-Catenin Signaling Regulatory Axis.

Mai Y, Li Z, Pang F, Zhou S, Li N, Wang Y Stem Cells Int. 2024; 2024:5388064.

PMID: 38633381 PMC: 11022505. DOI: 10.1155/2024/5388064.


References
1.
Nordin M, Bergman D, Halje M, Engstrom W, Ward A . Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif. 2014; 47(3):189-99. PMC: 6496486. DOI: 10.1111/cpr.12106. View

2.
Wu P, Zuo X, Deng H, Liu X, Liu L, Ji A . Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res Bull. 2013; 97:69-80. DOI: 10.1016/j.brainresbull.2013.06.001. View

3.
Kim E, Sung S . Long noncoding RNA: unveiling hidden layer of gene regulatory networks. Trends Plant Sci. 2011; 17(1):16-21. DOI: 10.1016/j.tplants.2011.10.008. View

4.
Harvey N, Dennison E, Cooper C . Osteoporosis: impact on health and economics. Nat Rev Rheumatol. 2010; 6(2):99-105. DOI: 10.1038/nrrheum.2009.260. View

5.
You W, Gao H, Fan L, Duan D, Wang C, Wang K . Foxc2 regulates osteogenesis and angiogenesis of bone marrow mesenchymal stem cells. BMC Musculoskelet Disord. 2013; 14:199. PMC: 3710500. DOI: 10.1186/1471-2474-14-199. View